vs
Side-by-side financial comparison of FIRST FINANCIAL CORP (THFF) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $70.5M, roughly 1.3× FIRST FINANCIAL CORP). FIRST FINANCIAL CORP runs the higher net margin — 30.4% vs 25.0%, a 5.4% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 14.1%). FIRST FINANCIAL CORP produced more free cash flow last quarter ($86.4M vs $12.8M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 20.8%).
First American Financial Corporation is an American financial services company which provides title insurance and settlement services to the real estate and mortgage industries.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
THFF vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.5M | $92.9M |
| Net Profit | $21.5M | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | 37.4% | 24.1% |
| Net Margin | 30.4% | 25.0% |
| Revenue YoY | 14.1% | 23.3% |
| Net Profit YoY | 32.1% | 17.3% |
| EPS (diluted) | $1.81 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $70.5M | $92.9M | ||
| Q3 25 | $65.8M | $67.5M | ||
| Q2 25 | $63.1M | $63.2M | ||
| Q1 25 | $62.5M | $52.6M | ||
| Q4 24 | $61.8M | $75.4M | ||
| Q3 24 | $58.4M | $57.9M | ||
| Q2 24 | $49.2M | $52.7M | ||
| Q1 24 | $48.4M | $51.3M |
| Q4 25 | $21.5M | $23.2M | ||
| Q3 25 | $20.8M | $5.1M | ||
| Q2 25 | $18.6M | $-553.0K | ||
| Q1 25 | $18.4M | $-11.2M | ||
| Q4 24 | $16.2M | $19.8M | ||
| Q3 24 | $8.7M | $-901.0K | ||
| Q2 24 | $11.4M | $-4.7M | ||
| Q1 24 | $10.9M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
| Q4 25 | 37.4% | 24.1% | ||
| Q3 25 | 39.2% | 5.1% | ||
| Q2 25 | 36.2% | -3.2% | ||
| Q1 25 | 38.1% | -24.3% | ||
| Q4 24 | 32.4% | 24.5% | ||
| Q3 24 | 17.9% | -4.3% | ||
| Q2 24 | 27.6% | -11.5% | ||
| Q1 24 | 27.2% | -10.7% |
| Q4 25 | 30.4% | 25.0% | ||
| Q3 25 | 31.6% | 7.5% | ||
| Q2 25 | 29.5% | -0.9% | ||
| Q1 25 | 29.5% | -21.4% | ||
| Q4 24 | 26.3% | 26.3% | ||
| Q3 24 | 15.0% | -1.6% | ||
| Q2 24 | 23.1% | -8.9% | ||
| Q1 24 | 22.6% | -7.5% |
| Q4 25 | $1.81 | $0.46 | ||
| Q3 25 | $1.75 | $0.10 | ||
| Q2 25 | $1.57 | $-0.01 | ||
| Q1 25 | $1.55 | $-0.23 | ||
| Q4 24 | $1.37 | $0.40 | ||
| Q3 24 | $0.74 | $-0.02 | ||
| Q2 24 | $0.96 | $-0.10 | ||
| Q1 24 | $0.93 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | $188.2M | — |
| Stockholders' EquityBook value | $650.9M | $354.6M |
| Total Assets | $5.8B | $488.0M |
| Debt / EquityLower = less leverage | 0.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M | ||
| Q1 24 | — | $110.6M |
| Q4 25 | $188.2M | — | ||
| Q3 25 | $170.5M | — | ||
| Q2 25 | $122.7M | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $28.1M | — | ||
| Q3 24 | $30.5M | — | ||
| Q2 24 | $108.6M | — | ||
| Q1 24 | $58.6M | — |
| Q4 25 | $650.9M | $354.6M | ||
| Q3 25 | $622.2M | $321.9M | ||
| Q2 25 | $587.7M | $306.8M | ||
| Q1 25 | $571.9M | $295.5M | ||
| Q4 24 | $549.0M | $292.0M | ||
| Q3 24 | $566.0M | $257.5M | ||
| Q2 24 | $530.7M | $243.0M | ||
| Q1 24 | $520.8M | $233.9M |
| Q4 25 | $5.8B | $488.0M | ||
| Q3 25 | $5.7B | $453.3M | ||
| Q2 25 | $5.6B | $435.6M | ||
| Q1 25 | $5.5B | $424.6M | ||
| Q4 24 | $5.6B | $432.7M | ||
| Q3 24 | $5.5B | $390.4M | ||
| Q2 24 | $4.9B | $376.8M | ||
| Q1 24 | $4.9B | $356.7M |
| Q4 25 | 0.29× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.21× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $90.4M | $15.0M |
| Free Cash FlowOCF − Capex | $86.4M | $12.8M |
| FCF MarginFCF / Revenue | 122.5% | 13.8% |
| Capex IntensityCapex / Revenue | 5.6% | 2.4% |
| Cash ConversionOCF / Net Profit | 4.21× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $144.3M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.4M | $15.0M | ||
| Q3 25 | $26.9M | $22.1M | ||
| Q2 25 | $12.7M | $8.2M | ||
| Q1 25 | $21.1M | $6.6M | ||
| Q4 24 | $60.4M | $22.2M | ||
| Q3 24 | $23.3M | $10.2M | ||
| Q2 24 | $8.8M | $18.5M | ||
| Q1 24 | $12.4M | $7.2M |
| Q4 25 | $86.4M | $12.8M | ||
| Q3 25 | $25.8M | $19.5M | ||
| Q2 25 | $11.6M | $81.0K | ||
| Q1 25 | $20.5M | $-7.6M | ||
| Q4 24 | $54.3M | $8.5M | ||
| Q3 24 | $19.5M | $-9.2M | ||
| Q2 24 | $8.4M | $1.8M | ||
| Q1 24 | $11.5M | $-6.8M |
| Q4 25 | 122.5% | 13.8% | ||
| Q3 25 | 39.2% | 28.8% | ||
| Q2 25 | 18.4% | 0.1% | ||
| Q1 25 | 32.8% | -14.5% | ||
| Q4 24 | 87.8% | 11.2% | ||
| Q3 24 | 33.5% | -15.9% | ||
| Q2 24 | 17.2% | 3.4% | ||
| Q1 24 | 23.7% | -13.3% |
| Q4 25 | 5.6% | 2.4% | ||
| Q3 25 | 1.7% | 3.9% | ||
| Q2 25 | 1.8% | 12.9% | ||
| Q1 25 | 0.9% | 27.0% | ||
| Q4 24 | 9.9% | 18.3% | ||
| Q3 24 | 6.5% | 33.5% | ||
| Q2 24 | 0.7% | 31.8% | ||
| Q1 24 | 2.0% | 27.3% |
| Q4 25 | 4.21× | 0.65× | ||
| Q3 25 | 1.29× | 4.35× | ||
| Q2 25 | 0.68× | — | ||
| Q1 25 | 1.14× | — | ||
| Q4 24 | 3.72× | 1.12× | ||
| Q3 24 | 2.67× | — | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 1.14× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
THFF
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
